SCHEMBL7814142

SCHEMBL7814142

CC(C)(Oc1ccc(C2(O)CCN(C(=O)c3cc(I)c(O)c(I)c3)CC2)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 1/20 0.44
PARP10 Q53GL7 2/20 0.44
PARP14 Q460N5 1/20 0.42
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA7 P43166 3/20 0.40
CA9 Q16790 3/20 0.40
CA14 Q9ULX7 3/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
LMNA P02545 4/20 0.39
PPARA Q07869 5/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811598 0.89 LMNA (0.46) SMN1; SMN2KDM4EPARP10PARP14CA12
SCHEMBL7814122 0.88 SMN1; SMN2 (0.46) SMN1; SMN2KDM4EPARP10PARP14CA12
SCHEMBL7809970 0.83 SMN1; SMN2 (0.60) SMN1; SMN2KDM4EMEN1CYP1A2CYP3A4
SCHEMBL7813630 0.83 ALDH1A1 (0.51) SMN1; SMN2KDM4ECA12CA1CA2
SCHEMBL7814073 0.83 SMN1; SMN2 (0.49) SMN1; SMN2KDM4EPARP10PARP14CA12
SCHEMBL7817568 0.82 ITGB3 (0.58) SMN1; SMN2KDM4EITGB3ITGA2BLMNA
SCHEMBL7811927 0.82 PARP10 (0.53) SMN1; SMN2KDM4EPARP10PARP14CA12
SCHEMBL7817546 0.80 PPARD (0.49) SMN1; SMN2KDM4EPARP10PARP14CA12
SCHEMBL7817531 0.80 HSD11B1 (0.46) PARP10PARP14CA12CA1CA2
SCHEMBL7813532 0.78 LMNA (0.42) SMN1; SMN2KDM4EPARP10PARP14CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed